Global Molecular Diagnostics Report: Market Size, Strategy and Forecasts 2015 to 2019

20:00 EDT 1 Jun 2015 | Globe Newswire

Dublin, June 02, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( has announced the addition of the "Molecular Diagnostics - Global Market Size, Strategy and Forecasts - 2015 to 2019" report to their offering.

"Molecular Diagnostics - Global Market Size, Strategy and Forecasts - 2015 to 2019" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2015 United States Medicare Fee Payment Schedules to help understand test pricing in detail.

See lists of all current FDA Approved Molecular Diagnostic Tests. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions. Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges.


  • Personalized medicine
  • Pharmacogenomics
  • Pathogen evolution
  • Next generation sequencing
  • Emergence of new economies with large markets
  • Greater understanding of the role of genetic material in Disease and Health

Detailed Market Forecasts provide Price, Volume and Revenue Forecasts individually broken out by year for Infectious Disease, Genetic Testing, Oncology Testing. Report Buyers have access to Price and Volume Data for the following individual tests:

  • Influenza
  • Tuberculosis
  • HIV
  • HBV
  • HCV
  • HPV
  • MRSA
  • VRSE
  • Chlamydia/gonorrhea
  • Prenatal
  • Blood Screening

Key Topics Covered:

1. Introduction and Market Definition

2. Market Overview

3. Market Trends

4. Molecular Diagnostics Recent Developments

5. Country Market Sizes - North America

6. Country Markets - Europe

7. Country Markets - Asia Pacific

8. Country Markets - Latin America, Africa & The Middle East

9. Global Market Summary

I. United States Medicare System: January 2015 Clinical Laboratory Fees Schedule - National Limit and Midpoint
II. FDA Approved Human Genetic Tests
III. FDA Approved Microbial Tests
III. FDA Approved Pharmacogenomics Tests

Companies Mentioned: 30 of the 300+ companies featured

- 14M Genomics
- 20/20 GeneSystems
- 23andMe
- 3M
- Abbott Diagnostics
- Abcam
- AbVitro
- Accelerate Diagnostics
- Acibadem Labmed Laboratory
- ACM Medical Laboratory
- ACT Genomics
- Adaptive Biotechnologies
- Adarza BioSystems
- Adicon Clinical Laboratories, Inc.
- Advanced Cell Diagnostics
- Aegis Sciences
- Aeris Capital
- Aetna
- Aetna Innovation Lab
- Agena Bioscience
- Agendia
- AITbiotech
- Alberta Investment Management
- Alere Inc
- Allegro Dx
- Alliance Global
- AltheaDx
- Amarantus BioScience
- American Liberty Petroleum
- American Pathology Partners, Inc.

For more information visit

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: Research and Markets
         Laura Wood, Senior Manager

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Healthcare and Medical Devices, Diagnostics

Primary Logo


More From BioPortfolio on "Global Molecular Diagnostics Report: Market Size, Strategy and Forecasts 2015 to 2019"

Quick Search


Relevant Topic

A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...